U.S. Markets closed

Emergent BioSolutions Looks Like It Will Get a Shot in the Arm

Bruce Kamich

, the vaccine maker with shares that are off 23% for the year amidst fears of a crackdown on drug prices. Kramer explained that Emergent began in 1998 in order to protect people from public health threats.